Health-care shares were higher.
Continue Reading Below
Shares of Endo International PLC plunged following a request from the FDA to voluntarily remove its Opana ER painkiller from the market amid abuse concerns. Thursday's request was the first of its kind and could be a telling sign for other painkiller producers. The FDA said, "the benefits of the drug may no longer outweigh its risks" given the country's opioid crisis.
-By Amy Pessetto, email@example.com
(END) Dow Jones Newswires
June 09, 2017 18:42 ET (22:42 GMT)